Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
CALL
Affirm
AFRM
$26.2B
| $154M | 0.03% |
3,396,900
-739,700
| -18% | -$43.8M |
|
477
Guardant Health
GH
$21.4B
| $153M | 0.03% |
3,596,913
+2,115,024
| +143% | +$91.2M |
|
478
PUT
Freeport-McMoran
FCX
$93.6B
| $153M | 0.03% |
4,040,900
+831,700
| +26% | +$31.8M |
|
479
AstraZeneca
AZN
$244B
| $150M | 0.03% |
1,023,111
-1,088,298
| -52% | -$157M |
|
480
CALL
Northrop Grumman
NOC
$81.6B
| $150M | 0.03% |
292,800
+104,900
| +56% | +$50.1M |
|
481
Evergy
EVRG
$19.3B
| $149M | 0.03% |
2,165,256
-17,060
| -0.8% | -$1.12M |
|
482
PUT
iShares MSCI EAFE ETF
EFA
$80.3B
| $149M | 0.03% |
1,822,600
-748,300
| -29% | -$60.3M |
|
483
PUT
Zscaler
ZS
$30.4B
| $149M | 0.03% |
749,900
-177,000
| -19% | -$35.3M |
|
484
Dover
DOV
$27.8B
| $148M | 0.03% |
844,297
-951,416
| -53% | -$183M |
|
485
CALL
DraftKings
DKNG
$12.6B
| $148M | 0.03% |
4,463,700
+357,500
| +9% | +$14.7M |
|
486
CALL
SLB Ltd
SLB
$77.3B
| $148M | 0.03% |
3,541,900
-619,400
| -15% | -$25.4M |
|
487
Watsco Inc
WSO
$12.9B
| $148M | 0.03% |
291,079
+129,432
| +80% | +$63.8M |
|
488
3M
MMM
$94.2B
| $148M | 0.03% |
1,005,217
-741,339
| -42% | -$109M |
|
489
Owens Corning
OC
$12.3B
| $148M | 0.03% |
1,033,259
-164,724
| -14% | -$27.2M |
|
490
Tenaris
TS
$26.6B
| $147M | 0.03% |
3,766,310
+1,688,609
| +81% | +$64.8M |
|
491
iShares Bitcoin Trust
IBIT
$47.2B
| $147M | 0.03% |
3,139,079
+2,076,388
| +195% | +$110M |
|
492
CALL
RTX Corp
RTX
$297B
| $147M | 0.03% |
1,108,200
-926,900
| -46% | -$118M |
|
493
CALL
Rivian
RIVN
$22.9B
| $146M | 0.03% |
11,733,800
-919,500
| -7% | -$11.6M |
|
|
494
PUT
RTX Corp
RTX
$297B
| $146M | 0.03% |
1,101,800
-346,500
| -24% | -$43.9M |
|
495
Credo Technology Group
CRDO
$49.6B
| $146M | 0.03% |
3,629,924
+2,203,416
| +154% | +$137M |
|
|
496
PUT
SLB Ltd
SLB
$77.3B
| $146M | 0.03% |
3,485,500
-1,602,500
| -31% | -$65.7M |
|
497
PUT
Accenture
ACN
$109B
| $146M | 0.03% |
466,900
+100,300
| +27% | +$35.4M |
|
498
DexCom
DXCM
$34.5B
| $145M | 0.03% |
2,127,423
-2,134,018
| -50% | -$174M |
|
499
CALL
Regeneron Pharmaceuticals
REGN
$83B
| $145M | 0.03% |
228,000
+59,400
| +35% | +$40.9M |
|
500
CALL
McKesson
MCK
$99.9B
| $144M | 0.03% |
214,200
+23,200
| +12% | +$14.3M |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.